Association for Behavior Analysis International

In this presentation, a review will be provided of the current medication used for individuals with autism and other developmental disabilities. In addition, I will describe the most commonly used behavioral measures, including rating scales, direct observation, and functional analysis measures and how they can be used within the context of medication evaluations. Recent research on other supplements used with individuals with autism and IDD will also be briefly described (e.g., cannabidiol or CBD). Finally, I will discuss how to collaborate effectively with schools, families, and interdisciplinary teams.

Target Audience: BCBAs, parents, school staff, undergraduate and graduate students

Learning Objectives: Following the conclusion of this webinar, participants will be able to: (1) discuss how individuals with developmental disabilities are treated with medications and possible side effects associated with medications (both behavioral and physiological effects); (2) utilize methods for effectively measuring medication effects with their clients or students in the community; (3) discuss recent research with recent over the counter supplements (e.g., cannabidiol) and how they may have psychotropic properties; (4) use provided information to effectively collaborate with interdisciplinary teams, families, and community services.